Integer CEO Khales Payman bought 3,127 shares of the company's stock on Oct. 30, 2025. Mr. Payman purchased his company's stock on the day shares hit a 52-week low of $62.
A new antimicrobial generic drug was approved by officials with the FDA for the treatment of canine skin infections: ...
This shift reflects what reports like McKinsey’s Global Payments Report for 2023, where digital payments continue to rise across both developed and emerging markets. In some countries, transactions ...
Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...
Sitecore heads to Orlando with new leadership, bold AI ambitions and fresh competition — here’s what CMSWire will be watching at Symposium 2025.
Procter & Gamble is a stable pick for income-focused investors, offering strong dividends and steady performance despite modest growth. See more on PG stock here.
StockStory.org on MSN
IART Q3 Deep Dive: Supply Chain Progress, Product Relaunches, and Margin Pressures Shape Outlook
Medical device company Integra LifeSciences (NASDAQ:IART) in Q3 CY2025, but sales rose 5.6% year on year to $402.1 million.
TIAA, the retirement-plan behemoth, also has a wealth management business with more than $200 billion of assets and nearly ...
All 18 of Jordon Hudson's side gigs outside of UNC football from beauty consulting to real estate originally appeared on The ...
Wolverine World Wide stock is still a "Hold." See why shares don't deserve an upgrade yet amid market uncertainty.
Income opportunity and multi-asset income funds ranked in the top third for the trailing three-year period and top half for ...
In this edition of “New Kid On The Block, we spoke to Wouter Samama, CEO and co-founder of OAASIS, to learn more about how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results